Skip to main content
. 2022 Aug 26;36(1):50–62. doi: 10.1093/ajh/hpac096

Table 3.

Association analysis of LVMI changes over time between vitamin D group and placebo group.

Variables at baseline Placebo Vitamin D Mean difference 95% CI P
Mean ± SD Mean ± SD Lower Upper
Group 90.70 ± 16.73 87.49 ± 14.33 3.20 −0.38 6.78 0.079
Age
 <45 years 93.29 ± 19.55 87.06 ± 16.42 6.23 −0.20 12.67 0.058
 ≥45 years 88.17 ± 13.06 87.77 ± 12.97 0.40 −3.59 4.40 0.842
BMI
 BMI <30 90.38 ± 13.57 87.75 ± 13.87 2.63 −3.40 8.67 0.388
 BMI ≥30 90.60 ± 18.09 87.42 ± 14.54 3.18 −1.29 7.65 0.162
Gender
 Female 83.42 ± 13.88 85.07 ± 13.74 1.65 −6.07 2.78 0.464
 Male 95.75 ± 16.74 92.19 ± 14.43 3.57 −2.06 9.19 0.213
Ever cigarette smoke
 No 88.33 ± 15.04 89.08 ± 14.17 0.75 −6.30 4.81 0.790
 Yes 92.43 ± 17.74 86.70 ± 14.42 5.73 1.04 10.42 0.017
Ever alcohol use
 No 91.28 ± 18.42 88.26 ± 12.36 3.03 −1.96 8.01 0.232
 Yes 89.87 ± 14.94 86.63 ± 16.35 3.25 −2.17 8.66 0.238
Diabetes
 No 91.17 ± 17.20 86.91 ± 14.72 4.26 0.35 8.18 0.033
 Yes 84.99 ± 7.63 91.04 ± 11.38 6.05 −13.63 1.53 0.114
HTN history
 <10 years 89.47 ± 15.27 85.62 ± 14.85 3.85 −1.08 8.78 0.125
 ≥10 years 92.65 ± 15.90 89.10 ± 13.68 3.55 −1.94 9.04 0.203
Dietary vitamin D supplement
 <Mean 90.59 ± 16.56 87.57 ± 15.13 3.02 −1.16 7.21 0.155
 ≥Mean 91.05 ± 17.54 87.28 ± 11.91 3.77 −3.31 10.85 0.291
Dietary calcium
 <Mean 90.91 ± 17.19 87.51 ± 16.02 3.41 −1.32 8.13 0.157
 ≥Mean 90.28 ± 15.95 87.47 ± 10.76 2.80 −2.55 8.15 0.301
Supplemental vitamin D
 No 90.77 ± 17.48 88.00 ± 14.81 2.77 −1.29 6.83 0.180
 Yes 90.38 ± 13.34 84.25 ± 10.51 6.13 −1.15 13.41 0.097
Supplemental calcium
 No 92.02 ± 18.36 88.46 ± 14.78 3.56 −1.00 8.11 0.125
 Yes 88.58 ± 13.60 84.07 ± 12.23 4.52 −1.27 10.30 0.124
Serum calcium
 <9 mg/dl 89.90 ± 17.71 88.30 ± 15.67 1.60 −4.55 7.74 0.607
 ≥9 mg/dl 91.16 ± 16.21 86.92 ± 13.36 4.24 −0.176 8.67 0.060
Serum creatinine
 <2 mg/dl 90.70 ± 16.73 87.49 ± 14.33 3.20 −0.38 6.78 0.079
 ≥2 mg/dl
Serum potassium
 ≤6 mmol/l 90.70 ± 16.73 87.61 ± 14.48 3.08 −0.54 6.71 0.095
 >6 mmol/l
Serum glucose
 ≤99 mg/dl 91.72 ± 17.60 85.19 ± 13.44 6.53 1.74 11.32 0.008
 > 99 mg/dl 89.23 ± 15.41 90.43 ± 14.99 1.20 −6.56 4.16 0.658
eGFR
 <60 ml/min/1.73 m2
 ≥60 ml/min/1.73 m2 90.70 ± 16.73 87.49 ± 14.33 3.20 −0.38 6.78 0.079
PTH
 <65 pg/ml 89.30 ± 14.03 88.38 ± 14.42 0.92 −3.26 5.11 0.664
 ≥65 pg/ml 93.12 ± 20.50 86.27 ± 14.24 6.85 0.38 13.33 0.038
Aldosterone
 <15 ng/dl 89.75 ± 15.41 86.98 ± 13.97 2.77 −0.76 6.30 0.124
 ≥15 ng/dl 99.60 ± 26.46 94.24 ± 17.99 5.36 −14.70 25.43 0.585
Plasma renin
 <1 ng/ml/h 91.55 ± 16.12 87.63 ± 14.69 3.92 −0.64 8.48 0.092
 ≥1 ng/ml/h 90.42 ± 17.71 87.34 ± 13.93 3.08 −3.07 9.23 0.323
ARR
 <25 90.52 ± 17.77 85.75 ± 13.13 4.77 0.81 8.73 0.019
 ≥25 91.60 ± 10.19 95.61 ± 17.02 4.01 −11.87 3.85 0.310
uACR
 <30 92.45 ± 16.22 87.05 ± 13.65 5.40 1.10 9.70 0.014
 ≥30 85.88 ± 19.21 89.09 ± 15.34 3.20 −11.26 4.86 0.431
BUN
 ≤20 mg/dl 89.25 ± 15.43 87.30 ± 14.50 1.95 −1.64 5.54 0.285
 >20 mg/dl 105.32 ± 22.37 90.34 ± 6.95 14.98 −1.12 31.08 0.067

Bold text represents values that are statistically significant with P < 0.05.

Note: Long data format. Abbreviations: ARR, aldosterone/renin ratio; BMI, body mass index; BUN, blood urea nitrogen; CI, confidence interval; Cr, creatinine; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HTN, hypertension; LVM, left ventricular mass; LVMI, left ventricular mass index; PTH, parathyroid hormone; SBP, systolic blood pressure; uACR, urine albumin/creatinine ratio.

Independent-sample t-test 2-sided P value.